Filing Details
- Accession Number:
- 0000919574-22-001656
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-14 20:15:12
- Reporting Period:
- 2022-02-10
- Accepted Time:
- 2022-02-14 20:15:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1074871 | Modular Medical Inc. | MODD | Surgical & Medical Instruments & Apparatus (3841) | 870620495 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1169253 | Manchester Management Co Llc | 2 Calle Candina, #1701 San Juan PR 00907 | No | No | Yes | Yes | |
1411524 | Manchester Explorer, L.p. | 2 Calle Candina, #1701 San Juan PR 00907 | No | No | Yes | No | |
1512127 | E James Besser | 2 Calle Candina, #1701 San Juan PR 00907 | No | No | Yes | No | |
1593072 | C. Morgan Frank | 2 Calle Candina, #1701 San Juan PR 00907 | Yes | No | Yes | No | |
1735534 | Manchester Management Pr, Llc | 2 Calle Candina, #1701 San Juan PR 00907 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-02-10 | 300,000 | $6.00 | 1,983,803 | No | 4 | P | Indirect | see footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | see footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Common Stock Purchase Warrant | Acquisiton | 2022-02-10 | 300,000 | $0.00 | 300,000 | $6.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
300,000 | 2022-02-10 | 2027-02-10 | No | 4 | A | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, Par Value $0.001 Per Share | 317,473 | Indirect | see footnote |
Common Stock, Par Value $0.001 Per Share | 124,750 | Direct | |
Common Stock, Par Value $0.001 Per Share | 60,277 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per | Convertible Promissory Not | $0.00 | 0 | 1,000,000 | Indirect | ||
Common Stock, Par Value $0.001 Per Share | Common Stock Purchase Warrant | $2.87 | 2022-02-06 | 2027-02-06 | 0 | 126,391 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
0 | 1,000,000 | Indirect | |
2027-02-06 | 0 | 126,391 | Indirect |
Footnotes
- Manchester Management Company, LLC ("Manchester Management") acquired 300,000 units consisting of one share of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share.
- The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- The reported securities are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- The reported securities are directly owned by James E. Besser in his personal capacity.
- The reported securities are directly owned by Morgan C. Frank in his personal capacity
- The Convertible Promissory Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued.
- The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.
- The Common Stock Purchase Warrant (the "Warrant") entitles the holder of the warrant to shares of Common Stock equal to the principal amount of the Note divided by $2.87. The Warrants are not convertible until 271 days after the issue date. The foregoing description of the Warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Common Stock Purchase Warrant included as Exhibit 10.22 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference.